NL-OMON37855已完成不适用
Validation of dried blood spot sampling in therapeutic drug monitoring of nilotinib - Dried Blood Spot Nilotinib
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with CML who are treated with nilotinib.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Validation of dried blood spot sampling in therapeutic drug monitoring of cyclosporiTransplantation of hematopoetic stem cells or kidney10003816NL-OMON34000Vrije Universiteit Medisch Centrum40
已完成
不适用
Clinical validation of the dried blood spot analysis for antituberculosis drugsBlood concentration of anti TB drugs10028440NL-OMON34891niversitair Medisch Centrum Groningen33
已完成
不适用
Clinical validation of a dried blood spot (DBS) method for the analysis of immunosuppressive and antifungal drugs in pediatric patients (part of the PROTECT study).immuunsuppressie na niertransplantatieanalysis of drug used in renal transplantation / analysis of drug used in invasive fungal infections10017528NL-OMON44369Afdeling Apotheek89
撤回
不适用
Clinical validation of a dried blood spot (DBS) method for the analysis of rifampicin (RIBOD study).analysis of drugs used for tuberculosis10004018NL-OMON42070niversitair Medisch Centrum Sint Radboud10
尚未招募
不适用
Validation of a finger prick capillary blood sampling test for home monitoring of C-reactive protein and therapeutic drug monitoring of biological therapy in patients with inflammatory bowel diseaseNL-OMON51794niversitair Medisch Centrum Groningen64